Sign inJoin waitlistJoin the waitlist

Wanxing Chai-Ho

Assistant Clinical Professor · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · · · · ·

History

UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Hematology and Medical Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
2015–2018
Internal Medicine
Lahey Clinic
2012–2015
Peking Union Medical College
2007–2011

Research

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Blood · 2021 · 295 citations
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
The Lancet Oncology · 2021 · 228 citations
Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment
Review · Chinese Journal of Cancer · 2013 · 139 citations

Deborah Wong
7 papers
Maie John
7 papers
DS
David Sallman
5 papers
Robert Chin
5 papers
AD
Amy DeZern
3 papers
Andrew Brunner
3 papers
Dinesh Chhetri
3 papers
Elliot Abemayor
3 papers
Guillermo Garcia-Manero
3 papers
Michael Ho
3 papers · 3 as a resident
Michael Steinberg
3 papers
Uma Borate
3 papers

Clinical trials

Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia
Principal investigator · Not yet recruiting · Phase 2
Jonsson Comprehensive Cancer Center
2026–2032
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Site PI · Recruiting · Phase 1, Phase 2
Disc Medicine, Inc
2022–2027